Department of Surgery and Interdisciplinary Medicine, University of Milano-Bicocca, Monza, Italy.
PLoS One. 2013 Apr 11;8(4):e61306. doi: 10.1371/journal.pone.0061306. Print 2013.
Nocturnal frontal lobe epilepsy has been historically considered a channelopathy caused by mutations in subunits of the neuronal nicotinic acetylcholine receptor or in a recently reported potassium channel. However, these mutations account for only a minority of patients, and the existence of at least a new locus for the disease has been demonstrated. In 2005, we detected two nucleotide variations in the promoter of the CRH gene coding for the corticotropin releasing hormone in 7 patients. These variations cosegregated with the disease and were demonstrated to alter the cellular levels of this hormone. Here, we report the identification in an Italian affected family of a novel missense mutation (hpreproCRH p.Pro30Arg) located in the region of the CRH coding for the protein pro-sequence. The mutation was detected in heterozygosity in the two affected individuals. In vitro assays demonstrated that this mutation results in reduced levels of protein secretion in the short time thus suggesting that mutated people could present an altered capability to respond immediately to stress agents.
夜间额叶癫痫在历史上被认为是一种通道病,由神经元烟碱型乙酰胆碱受体亚单位或最近报道的钾通道的突变引起。然而,这些突变仅占少数患者,并且至少存在疾病的新位点已经得到证明。2005 年,我们在 7 名患者中检测到促肾上腺皮质激素释放激素(CRH)基因启动子中的两个核苷酸变异。这些变异与疾病共分离,并证明改变了这种激素的细胞水平。在这里,我们报告了在一个意大利受影响的家族中发现了一种新的错义突变(hpreproCRH p.Pro30Arg),位于 CRH 编码蛋白前导序列的区域。该突变在两个受影响的个体中以杂合性存在。体外检测表明,该突变导致短时间内蛋白质分泌水平降低,这表明突变个体可能对应激原的反应能力发生改变。